FDA Clearance Tracker · P980053-S018
Durasphere Injectable Bulking Agent
Last checked: Nov 20, 2026Latest source record: Feb 25, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Feb 25, 2021
Approved
Time to decision
59 days
Received Dec 28, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P980053-S018
- Device name
- Durasphere Injectable Bulking Agent
- Applicant
- Carbon Medical Technologies, Inc.
- Applicant location
- St. Paul, MN
- Received
- Dec 28, 2020
- Decided
- Feb 25, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P980053
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at Steris, 9303 West Broadway Ave., Brooklyn Park, MN 55445, a contract sterilizer.
Source documents
Other decisions for Carbon Medical Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K253598 · Decided Mar 31, 2026 · 133 days after receipt
Device type: Endoscopic Injection Needle, Gastroenterology-Urology (FBK) · GI, Urology & Nephrology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.